|
業務類別
|
-- |
|
業務概覽
|
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. |
| 公司地址
| 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045 |
| 電話號碼
| +81 662035708 |
| 傳真號碼
| +81 662026028 |
| 公司網頁
| https://www.sumitomo-pharma.com |
| 員工數量
| 3123 |
| Mr. Toru Kimura |
Director, President and Chief Executive Officer |
-- |
23/06/2026 |
| Mr. Motoyuki Sakai |
Director and Executive Vice President |
-- |
23/06/2026 |
| Mr. Tsutomu Nakagawa |
Director and Managing Executive Officer |
-- |
23/06/2026 |
|
|
| Mr. Toru Kimura |
Director, President and Chief Executive Officer |
23/06/2026 |
| Mr. Minoru Usui |
Independent Director |
23/06/2026 |
| Mr. Hiroshi Niinuma |
Director |
23/06/2026 |
| Mr. Koji Fujimoto |
Independent Director |
23/06/2026 |
| Mr. Motoyuki Sakai |
Director and Executive Vice President |
23/06/2026 |
| Mr. Tsutomu Nakagawa |
Director and Managing Executive Officer |
23/06/2026 |
| Mr. Hisayoshi Kashima |
Director |
23/06/2026 |
| Mr. Yoshio Iteya |
Independent Director |
23/06/2026 |
| Ms. Mayumi Mochizuki |
Independent Director |
23/06/2026 |
| Mr. Daishiro Michimori |
Independent Director |
23/06/2026 |
|
|
|
|
